publication venue for
- Abstract B59: Co-evolution between tumor cells and immune system in the setting of T-cell immunotherapy. 8:b59-b59. 2020
- Abstract B41: Bis-indole derived NR4A1 antagonist induces PD-L1 degradation and enhances antitumor immunity. 8:b41-b41. 2020
- PBRM1 loss promotes resistance to immunotherapy in RCC. 2020